Skip to content
Human-limitedGonadotropin-releasing hormone agonist

Gonadorelin

GnRH analog for fertility and hormonal assessment.

Overview

Binds to GnRH receptors on pituitary gonadotroph cells, triggering calcium flux and hormone synthesis/secretion.

Proposed mechanism

Gonadorelin is synthetic luteinizing hormone-releasing hormone (LHRH) stimulating pituitary release of LH and FSH, used both diagnostically and therapeutically.

What the evidence supports

Human data exists but the trials are small, short-term, or not yet replicated.

Graded Human-limited

Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.

Key citations

Representative primary sources, including results that did not favour the compound.

  1. [1]

    Gonadorelin in hypogonadism

    · DOI:10.1210/jc.2002-021230 · 2003

  2. [2]

    GnRH therapy

    · DOI:10.1210/er.2014-1018 · 2014

  3. [3]

    Gonadorelin in hypogonadism (2003)

    · · 0

  4. [4]

    GnRH therapy (2014)

    · · 0

Citation records in this build are illustrative placeholders for the design.

Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.

Related profiles